ID=H0692
URL=http://www.ornl.gov/TechResources/Human_Genome/elsi/patents.html
SIZE=52521
DATE=11/07/2002
TIME=17:07:13
DATASET=Biology
HTML=<!doctype html public "-//w3c//dtd html 4.0 transitional//en">
<html>
<head>
  
   <title>Genetics and Patenting</title>

<META name="description" content="Information about genetics and patenting --what is required, potential positive and negative effects, laws governing gene patenting, etc.">
   <META NAME="keywords" CONTENT="genetics, gene, genome, hgp, biology, BAC, bacterial artificial chromosome, base pairs, bioinformatics, biology, comparative genomics, functional genomics, genome function, chromosome, elsi, ethical issues, legal issues, social issues,
gene testing, gene therapy, genetic publications, genetics legislation, genetics issues, genome meetings, genome calendar, publications, genomic libraries, clones, snps, instrumentation, linkage mapping, microbial genome project, mRNA, sequencing technologies, sequencing, genome project, human genome news, goals, mapping, national institutes of health, primer on molecular genetics, to know ourselves, DNA, human genetics, Human Genome Project, Department of Energy, patenting, privacy, insurance, education, human genetics, DNA sequencing, DNA mapping">


<html>
<head>
<META name="description" content="Explore the ethical, legal, and social issues (ELSI)
surrounding availability of genetic information, and learn more about ELSI goals including
privacy of genetic information, safe and effective introduction of genetic information in the clinical
setting, fairness in the use of genetic information, and professional and public education."> 
<META NAME="keywords" 
content="ethical issues, legal issues, social issues, gene testing, cloning, gene patenting, genetic
network, to know ourselves, your genes your choices, genetic issues, HGP, human genome
project, genetics legislation, genome, genetic counseling, genetics, DNA, patenting, privacy,
insurance, education, ELSI">

<title>Human Genome Project: Ethical, Legal, & Social Issues</title>
<meta http-equiv="Content-Type" content="text/html; charset=iso-8859-1">
<meta name="description" content="Fireworks Splice HTML">

<!-- Fireworks 2.0  Dreamweaver 2.0 target.  Created Mon Apr 24 15:40:04 GMT-0400 (Eastern Daylight Time) 2000 -->

<!-------------------- BEGIN COPYING THE JAVASCRIPT SECTION HERE ------------------->

<script language="JavaScript">

<!--hide this script from non-javascript-enabled browsers


function MM_displayStatusMsg(msgStr) {
    status = msgStr;
    document.MM_returnValue = true;
}


function MM_preloadImages() { //v2.0
  if (document.images) {
    var imgFiles = MM_preloadImages.arguments;
    if (document.preloadArray==null) document.preloadArray = new Array();
    var i = document.preloadArray.length;
    with (document) for (var j=0; j<imgFiles.length; j++) if (imgFiles[j].charAt(0)!="#"){
      preloadArray[i] = new Image;
      preloadArray[i++].src = imgFiles[j];
  } }
}

function MM_swapImgRestore() { //v2.0
  if (document.MM_swapImgData != null)
    for (var i=0; i<(document.MM_swapImgData.length-1); i+=2)
      document.MM_swapImgData[i].src = document.MM_swapImgData[i+1];
}

function MM_swapImage() { //v2.0
  var i,j=0,objStr,obj,swapArray=new Array,oldArray=document.MM_swapImgData;
  for (i=0; i < (MM_swapImage.arguments.length-2); i+=3) {
    objStr = MM_swapImage.arguments[(navigator.appName == 'Netscape')?i:i+1];
    if ((objStr.indexOf('document.layers[')==0 && document.layers==null) ||
        (objStr.indexOf('document.all[')   ==0 && document.all   ==null))
      objStr = 'document'+objStr.substring(objStr.lastIndexOf('.'),objStr.length);
    obj = eval(objStr);
    if (obj != null) {
      swapArray[j++] = obj;
      swapArray[j++] = (oldArray==null || oldArray[j-1]!=obj)?obj.src:oldArray[j];
      obj.src = MM_swapImage.arguments[i+2];
  } }
  document.MM_swapImgData = swapArray; //used for restore
}
//-->
</script>

<!-------------------------- STOP COPYING THE JAVASCRIPT HERE -------------------------->

</head>

<body bgcolor="#ffffff" text="#000000" topmargin="0" onLoad="MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r5_c01.gif','#963939329718');MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r6_c06.gif','#963939424354');MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r4_c07.gif','#963939453336');MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r5_c09.gif','#963939474947');MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r6_c11.gif','#963939505050');MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r6_c14.gif','#963939523266');MM_preloadImages('http://www.ornl.gov/hgmis/images/head/elsi2_r5_c17.gif','#963939547761')">
<font  size="-2"><a href="#navbottom"><font size="-2">skip navigation</font></a></font> 
<!-- Image with table -->
<!--   This table was automatically created with Macromedia Fireworks 2.0   -->
<!--   http://www.macromedia.com   -->
<div align="center">
  <table border="0" cellpadding="0" cellspacing="0" width="545">
    <tr><!-- spacing row, 1 height. --> 
      <td><img name="FwShim_Col_0" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="94" height="1" border="0"></td>
      <td><img name="FwShim_Col_1" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_2" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_3" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_4" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_5" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="91" height="1" border="0"></td>
      <td><img name="FwShim_Col_6" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="82" height="1" border="0"></td>
      <td><img name="FwShim_Col_7" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_8" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="8" height="1" border="0"></td>
      <td><img name="FwShim_Col_9" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="67" height="1" border="0"></td>
      <td><img name="FwShim_Col_10" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="27" height="1" border="0"></td>
      <td><img name="FwShim_Col_11" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_12" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="39" height="1" border="0"></td>
      <td><img name="FwShim_Col_13" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="47" height="1" border="0"></td>
      <td><img name="FwShim_Col_14" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
      <td><img name="FwShim_Col_15" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="15" height="1" border="0"></td>
      <td><img name="FwShim_Col_16" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="68" height="1" border="0"></td>
    </tr>
    <tr><!-- row 1 --> 
      <td colspan="2" rowspan="2"><a href="http://www.ornl.gov/hgmis/" onMouseOut="MM_displayStatusMsg(' ');return document.MM_returnValue"  onMouseOver="MM_displayStatusMsg('');return document.MM_returnValue" ><img  src="http://www.ornl.gov/hgmis/images/head/logo.gif" name="logo" width="95" height="53" border="0" alt="Home"></a></td>
      <td rowspan="3" colspan="4"><a href="http://www.ornl.gov/hgmis/toc_expand.html"><img  src="http://www.ornl.gov/hgmis/images/head/index.gif" name="index" width="94" height="54" border="0" alt="Site Index"></a></td>
      <td colspan="11"><a href="http://www.ornl.gov/hgmis/"><img  src="http://www.ornl.gov/hgmis/images/head/title.gif" name="title" width="356" height="30" border="0" alt="Home"></a></td>
      <td rowspan="2"><img name="FwShim_Row_0" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="53" border="0"></td>
    </tr>
    <tr> 
      <td colspan="11"><a href="http://www.ornl.gov/hgmis/archive/news.html"><img src="http://www.ornl.gov/hgmis/images/head/news.gif" width="90" height="24" alt="What's New" border="0"></a></td>
    </tr>
    <tr><!-- row 2 --> 
      <td rowspan="3"><a href="http://www.ornl.gov/hgmis/project/about.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r2_c01.gif" name="elsi_r2_c01" width="94" height="24" border="0" alt="About the HGP"></a></td>
      <td rowspan="3"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r2_c02.gif" name="elsi_r2_c02" width="1" height="24" border="0"></td>
      <td colspan="3"><a href="http://www.ornl.gov/hgmis/"><img  src="http://www.ornl.gov/hgmis/images/head/shim.gif" name="title" width="91" height="1" border="0" alt="Home"></a></td>
      <td rowspan="2" colspan="3"><a href="http://www.ornl.gov/hgmis/elsi/elsi.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r2_c10.gif" name="elsi_r2_c10" width="95" height="23" border="0" alt="Ethical, Legal, and Social Issues"></a></td>
      <td colspan="5"><a href="http://www.ornl.gov/hgmis/"><img  src="http://www.ornl.gov/hgmis/images/head/shim.gif" name="title" width="170" height="1" border="0" alt="Home"></a></td>
      <td><img name="FwShim_Row_1" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
    </tr>
    <tr><!-- row 3 --> 
      <td colspan="4"><a href="http://www.ornl.gov/hgmis/research/research.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r3_c03.gif" name="elsi_r3_c03" width="94" height="22" border="0" alt="Research"></a></td>
      <td colspan="3"><a href="http://www.ornl.gov/hgmis/education/education.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r3_c07.gif" name="elsi_r3_c07" width="91" height="22" border="0" alt="Education"></a></td>
      <td colspan="2"><a href="http://www.ornl.gov/hgmis/medicine/medicine.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r3_c13.gif" name="elsi_r3_c13" width="86" height="22" border="0" alt="Medicine"></a></td>
      <td rowspan="3"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r3_c15.gif" name="elsi_r3_c15" width="1" height="24" border="0"></td>
      <td colspan="2"><a href="http://www.ornl.gov/hgmis/resource/media.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r3_c16.gif" name="elsi_r3_c16" width="83" height="22" border="0" alt="Media"></a></td>
      <td><img name="FwShim_Row_2" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="22" border="0"></td>
    </tr>
    <tr><!-- row 4 --> 
      <td><a href="http://www.ornl.gov/hgmis/medicine/genetherapy.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r4_c03.gif" name="elsi_r4_c03" width="1" height="1" border="0" alt="Gene Therapy"></a></td>
      <td><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r4_c04.gif" name="elsi_r4_c04" width="1" height="1" border="0"></td>
      <td rowspan="2" colspan="2"><a href="http://www.ornl.gov/hgmis/medicine/genetherapy.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r4_c05.gif" name="elsi_r4_c05" width="92" height="2" border="0" alt="Gene Therapy"></a></td>
      <td rowspan="4" colspan="2"><a href="http://www.ornl.gov/hgmis/elsi/legislat.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r4_c07','document.elsi_r4_c07','http://www.ornl.gov/hgmis/images/head/elsi2_r4_c07.gif','#963939453336')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r4_c07.gif" name="elsi_r4_c07" width="83" height="24" border="0" alt="Privacy Issues and Other Legislation"></a></td>
      <td colspan="6"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r4_c09.gif" name="elsi_r4_c09" width="189" height="1" border="0"></td>
      <td colspan="2"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r4_c16.gif" name="elsi_r4_c16" width="83" height="1" border="0"></td>
      <td><img name="FwShim_Row_3" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
    </tr>
    <tr><!-- row 5 --> 
      <td rowspan="3" colspan="3"><a href="http://www.ornl.gov/hgmis/medicine/genetest.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r5_c01','document.elsi_r5_c01','http://www.ornl.gov/hgmis/images/head/elsi2_r5_c01.gif','#963939329718')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r5_c01.gif" name="elsi_r5_c01" width="96" height="23" border="0" alt="Gene Testing"></a></td>
      <td rowspan="3"><a href="http://www.ornl.gov/hgmis/medicine/genetherapy.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r5_c04.gif" name="elsi_r5_c04" width="1" height="23" border="0" alt="Gene Therapy"></a></td>
      <td rowspan="3" colspan="2"><a href="http://www.ornl.gov/hgmis/elsi/patents.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r5_c09','document.elsi_r5_c09','http://www.ornl.gov/hgmis/images/head/elsi2_r5_c09.gif','#963939474947')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r5_c09.gif" name="elsi_r5_c09" width="75" height="23" border="0" alt="Patenting Issues in Genetics"></a></td>
      <td colspan="4"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r5_c11.gif" name="elsi_r5_c11" width="114" height="1" border="0"></td>
      <td><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r5_c16.gif" name="elsi_r5_c16" width="15" height="1" border="0"></td>
      <td rowspan="3"><a href="http://www.ornl.gov/hgmis/elsi/behavior.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r5_c17','document.elsi_r5_c17','http://www.ornl.gov/hgmis/images/head/elsi2_r5_c17.gif','#963939547761')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r5_c17.gif" name="elsi_r5_c17" width="68" height="23" border="0" alt="Other Ethical, Legal, and Social Issues"></a></td>
      <td><img name="FwShim_Row_4" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
    </tr>
    <tr><!-- row 6 --> 
      <td><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r6_c05.gif" name="elsi_r6_c05" width="1" height="1" border="0"></td>
      <td rowspan="2"><a href="http://www.ornl.gov/hgmis/medicine/genetherapy.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r6_c06','document.elsi_r6_c06','http://www.ornl.gov/hgmis/images/head/elsi2_r6_c06.gif','#963939424354')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r6_c06.gif" name="elsi_r6_c06" width="91" height="22" border="0" alt="Gene Therapy"></a></td>
      <td rowspan="2" colspan="3"><a href="http://www.ornl.gov/hgmis/elsi/forensics.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r6_c11','document.elsi_r6_c11','http://www.ornl.gov/hgmis/images/head/elsi2_r6_c11.gif','#963939505050')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r6_c11.gif" name="elsi_r6_c11" width="67" height="22" border="0" alt="DNA Forensics"></a></td>
      <td rowspan="2" colspan="3"><a href="http://www.ornl.gov/hgmis/courts/courts.html" onMouseOut="MM_swapImgRestore()" onMouseOver="MM_swapImage('document.elsi_r6_c14','document.elsi_r6_c14','http://www.ornl.gov/hgmis/images/head/elsi2_r6_c14.gif','#963939523266')"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r6_c14.gif" name="elsi_r6_c14" width="63" height="22" border="0" alt="Courts and the New Genetics"></a></td>
      <td><img name="FwShim_Row_5" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="1" border="0"></td>
    </tr>
    <tr><!-- row 7 --> 
      <td><a href="http://www.ornl.gov/hgmis/medicine/genetherapy.html"><img  src="http://www.ornl.gov/hgmis/images/head/elsi_r7_c05.gif" name="elsi_r7_c05" width="1" height="21" border="0" alt="Gene Therapy"></a></td>
      <td><img name="FwShim_Row_6" src="http://www.ornl.gov/hgmis/images/head/shim.gif" width="1" height="21" border="0"></td>
    </tr>
  </table>
</div>


<CENTER><B><FONT SIZE=+2>Genetics and Patenting</font></b></center>
    <hr noshade> 
<TABLE COLS=2 WIDTH="100%" BGCOLOR="#FFFFFF" border="0"> 

<TR> 
    <TD ALIGN=LEFT VALIGN=TOP  WIDTH="15%" BGCOLOR="#FFFFCC"> <font face="Arial, Helvetica, sans-serif size="-2 color="#CC0000""><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8 WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/toc_expand.html"><font size="-2">Subject 
      Index</font></a></FONT><BR>
      <font face="Arial, Helvetica, sans-serif" size="-2"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8 WIDTH=8>&nbsp;<FONT
COLOR="#CC0000"><A HREF="http://www.ornl.gov/hgmis/toc_expand.html#alpha">Alphabetical Index</a></FONT></font>
<P><font face="Arial, Helvetica, sans-serif"><B><font color="#CC0000" size="-1">News</font></B><BR>
      <font size="-2"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8 WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/archive/news.html">What's 
      New</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8 width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/archive/headlines.html">Genetics 
      Headlines</a><br>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/publicat/hgn/hgn.html">Human 
      Genome News</a></font></font><font face="Arial, Helvetica, sans-serif" size="-2"><br>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8 WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/CAL.HTML">Meetings Calendar</a><br>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8 WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/resource/media.html">Media Guide</a> </font>
      <p><font color="#CC0000" face="Arial, Helvetica, sans-serif" size="-1"><b>Basic 
        Information</b></font> <font face="Arial, Helvetica, sans-serif"><br>
        <font color="#000000" size="2"> <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8><font size="-2">&nbsp;<a href="http://www.ornl.gov/hgmis/faq/faqs1.html">FAQs</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/TechResources/Human_Genome/glossary/">Glossary</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/acronym.html">Acronyms</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/links.html">Links</a><br>
        </font><font color="#000000" face="Arial, Helvetica, sans-serif"><font size="-2"><img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/project/info.html">Genetics 101</a><br>
        </font><font face="Arial, Helvetica, sans-serif" size="-2" color="#000000"><img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/publicat/publications.html">Publications</a></font></font><font size="-2"><br>
        </font></font></font></p>
    <P> 
    <FONT COLOR="#000000">
    <P><font face="Arial, Helvetica, sans-serif"><B><font color="#CC0000" size="-1">About 
      the Project</font></B><br>
        </font> <font color="#000000" face="Arial, Helvetica, sans-serif" size="2"> 
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<font size="-2"><A
HREF="http://www.ornl.gov/hgmis/project/about.html">What is it?</a><BR>
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hg5yp">Goals</a><BR>
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/project/progress.html">Progress</a><BR>
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/project/hgp.html">History</a><BR>
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/elsi/elsi.html">Ethical Issues</a><BR>
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/project/benefits.html">Benefits</a><BR>
        <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/project/info.html">Genetics 101</a><BR>
        </font> </font>
      <P><font face="Arial, Helvetica, sans-serif"><B><FONT COLOR="#CC0000" size="-1">Medicine 
        &amp;<br>
        the New Genetics</FONT></B><br>
        <font color="#000000" size="2"><img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/medicine/medicine.html"><font size="-2">Home</font></a><font size="-2"><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/medicine/genetest.html">Gene 
        Testing</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/medicine/genetherapy.html">Gene 
        Therapy</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8 width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/medicine/pharma.html">Pharmacogenomics</a></font></font></font><font size="-2" face="Arial, Helvetica, sans-serif"><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/medicine/assist.html">Disease Information</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/medicine/genecounseling.html">Genetic 
        Counseling</a></font> 
      </font> 
      <P><font color="#000000" face="Arial, Helvetica, sans-serif"><b><font color="#CC0000" size="-1">Ethical, 
        Legal,<BR>
        Social Issues</font></b><br>
      <font size=2> <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/elsi/elsi.html"><font size="-2">Home</font></a><font size="-2"><BR>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/elsi/legislat.html">Privacy Legislation</a></font></font><font face="Arial, Helvetica, sans-serif" size="-2"><BR>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/medicine/genetest.html">Gene 
      Testing</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/elsi/patents.html">Patenting</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/elsi/forensics.html">Forensics</a><br>
        </font><font color="#000000" face="Arial, Helvetica, sans-serif" size="-2"><img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/elsi/gmfood.html">Genetically 
        Modified Food</a></font><font face="Arial, Helvetica, sans-serif" size="-2"><br>
      </font><font face="Arial, Helvetica, sans-serif" size="-2"> <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/elsi/behavior.html">Behavioral 
      Genetics</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
 width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/courts/courts.html">Genetics 
      in Courtroom</a></font></font> 
      <P><font face="Arial, Helvetica, sans-serif" size="-1" color="#CC0000"><B>Education</B></font><BR>
      <font color="#000000" size="-2" face="Arial, Helvetica, sans-serif"> <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8 
WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/education/education.html">Teachers</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/education/careers.html">Careers</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/education/students.html">Students</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/education/audio.html">Webcasts 
      Audio/Video</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A HREF="http://www.ornl.gov/hgmis/education/images.html">Images</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
 WIDTH=8>&nbsp;<a href="http://www.ornl.gov/hgmis/education/videos.html">Videos</a><BR>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/posters/chromosome/">Chromosome 
      Poster</a><BR>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
 width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/graphics/slides/talks.html">Presentations</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8 
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/project/info.html">Genetics 101</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8 
width=8>&nbsp;</font><font size="-2" face="Arial, Helvetica, sans-serif"><a href="http://www.ornl.gov/hgmis/education/spanish.html">Genética 
        Websites en Español</a></font> 
      <P><font face="Arial, Helvetica, sans-serif" color="#CC0000" size="-1"><B>Research<br>
        in Progress</B></font><BR>
        <font face="Arial, Helvetica, sans-serif"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/research/research.html"><font size="-2">Home</font></a><BR><font size="-2"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/research/sequencing.html">Sequencing</a><BR><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<a href="http://www.ornl.gov/hgmis/research/instrumentation.html">Instrumentation</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/research/mapping.html">Mapping</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/research/informatics.html">Bioinformatics</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<a href="http://www.ornl.gov/hgmis/research/function.html">Functional 
      Genomics</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/research/elsi.html">ELSI Research</a><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/publicat/00santa">Recent Abstracts</A><BR>
      <IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<a href="http://www.ornl.gov/hgmis/research/centers.html">US,Intl. 
      Research Sites</a><BR></font>
      <font size="-2"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/funding/fund.html">Funding</a></font></font></p>
    <p>
    <b><font color="#CC0000" size="-1" face="Arial, Helvetica, sans-serif">Publications</font></b><BR>
    <font size="-2"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<a href="http://www.ornl.gov/hgmis/publicat/hgn/hgn.html"><font face="Arial, Helvetica, sans-serif">Human 
    Genome News</font><br>
      </a></font>

<font size="-2" face="Arial, Helvetica, sans-serif">
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/posters/chromosome/">Chromosome Poster</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/publicat/primer/intro.html">Primer Molecular Genetics</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/publicat/tko/index.html">To Know Ourselves</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/publicat/genechoice/index.html">Your Genes, Your 
      Choices</a><br>
      <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/publicat/02santa/index.html">2002 DOE Genome Abstracts</a><br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a
href="http://www.ornl.gov/hgmis/publicat/publications.html">List of All Publications</a> 
        </font> 
      <p>&nbsp; 
      <FONT COLOR="#000000"> <font face="Arial, Helvetica, sans-serif"><B><FONT COLOR="#CC0000"><IMG
SRC="http://www.ornl.gov/hgmis/graphics/question.gif" HEIGHT=28
WIDTH=25 alt="???"><font size="-1">Search This Site</font></FONT></B><BR>
      </font> 
      <FORM METHOD="POST"
ACTION="http://www-search.ornl.gov:8000/otcgi/llscgi60.exe">
        <font face="Arial, Helvetica, sans-serif" size="-2"> 
        <INPUT TYPE="hidden" NAME="query"
VALUE="www.ornl.gov/TechResources/Human_Genome">
        <INPUT TYPE="hidden" NAME="region" VALUE="U">
        <INPUT NAME="query" SIZE="10">
        <INPUT TYPE="hidden" NAME="region" VALUE="">
        <INPUT TYPE="hidden" NAME="db" VALUE="6">
        <INPUT TYPE="hidden" NAME="mode" VALUE="and">
        <INPUT TYPE="hidden" NAME="op" VALUE="not">
        <INPUT TYPE="hidden" NAME="query"
VALUE="//www.ornl.gov/TechResources/Human_Genome/publicat">
        <INPUT TYPE="hidden" NAME="region" VALUE="U">
        <INPUT TYPE="hidden" NAME="op" VALUE="and">
        <BR>
        <INPUT TYPE="submit" VALUE="Search">
        <INPUT
TYPE="reset">
        </font> 
      </FORM>
      <BR>
      <FORM METHOD="POST"
ACTION="http://www-search.ornl.gov:8000/otcgi/llscgi60.exe">
        <font face="Arial, Helvetica, sans-serif" size="-2"> Search Web pages<BR>
        plus publications<BR>
        <INPUT TYPE="hidden" NAME="query"
VALUE="www.ornl.gov/TechResources/Human_Genome">
        <INPUT TYPE="hidden" NAME="region" VALUE="U">
        <INPUT NAME="query" SIZE="10">
        <INPUT TYPE="hidden" NAME="region" VALUE="">
        <INPUT TYPE="hidden" NAME="db" VALUE="6">
        <INPUT TYPE="hidden" NAME="mode" VALUE="and">
        <INPUT TYPE="hidden" NAME="op" VALUE="and">
        <BR>
        <INPUT TYPE="submit" VALUE="Search">
        <INPUT
TYPE="reset">
        </font> 
      </FORM>
      <P><font face="Arial, Helvetica, sans-serif" size="-2"><IMG SRC="http://www.ornl.gov/hgmis/graphics/whitebal.gif" HEIGHT=8
WIDTH=8>&nbsp;<A
HREF="http://www.ornl.gov/hgmis/contact.html">Contact Us</a> <br>
        <img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8>&nbsp;<a href="http://www.ornl.gov/hgmis/privacy2.html">Privacy Statement</a></font><font size="-2"><BR>
        </font><font color="#000000" size="-2"><img src="http://www.ornl.gov/hgmis/graphics/whitebal.gif" height=8
width=8></font><font face="Arial, Helvetica, sans-serif" size="-2">&nbsp;<A
HREF="http://www.ornl.gov/hgmis/stats.html">Site Stats and Credits</a> </font> 
      </font></TD>
    <TD ALIGN=LEFT VALIGN=TOP BGCOLOR="#FFFFFF"><a name="navbottom"></a>
  
<p><b>Quick Links to this Page</b></p>
<UL>
  <LI><a href="#1">What are patents, and how do they work?</a> 
  <LI><a href="#2">Patenting Gene Fragments, SNPS, Proteins, Genes, Gene Tests</a> 
  <LI><a href="#3">Why patent?</a> 
  <LI><a href="#4">What are some of the potential arguments in favor of gene patenting?</a> 
  <LI><a href="#5">What are some of the negative positive arguments against gene 
    patenting?</a> 
  <LI> 
    <p><a href="#6">What laws govern gene patenting?</a> 
  <LI><a href="#7">How does genome information placed in the public domain work? 
    Who can use it?</a> 
</ul>
<p><b><a name="1"></a>What are patents, and how do they work?</b></p>
<p>The patentability of inventions under U.S. law is determined by the Patent 
  and Trademark Office (USPTO) in the Department of Commerce. A patent application 
  is judged on four criteria. The invention must be "useful" in a practical sense 
  (the inventor must identify some useful purpose for it), "novel" (i.e., not 
  known or used before the filing), and "nonobvious" (i.e., not an improvement 
  easily made by someone trained in the relevant area). The invention also must 
  be described in sufficient detail to enable one skilled in the field to use 
  it for the stated purpose (sometimes called the "enablement" criterion). </p>
<p>In general, raw products of nature are not patentable.&nbsp; It's usually when 
  these DNA products have been isolated, purified, or modified to produce a unique 
  form not found in nature that they become patentable. </p>
<P>The USPTO has 3 years to issue a patent. In Europe, the timeframe is 18 months. 
  The USPTO is adopting a similar system. Patents are good for 20 years from filing 
  date. 
<P>In the United States, patent priority is based on the "first to invent" principle: 
  whoever made the invention first (and can prove it) is awarded property rights 
  for the 20-year period. Inventors have a one-year grace period to file after 
  they publish. All other countries except the Philippines, however, follow a 
  "first inventor to file" rule in establishing priority when granting patents. 
      <P> Many biotech patents have been applied for as provisional patents. This 
        means that persons or companies filing the provisional patent application 
        have up to one year to file their actual patent claim. The provisional 
        patent must contain a written description of said invention and the names 
        of the inventors. This one-year grace period does not count as one of 
        the 20 years that the patent is issued for. 
      <P>When a biotechnology patent involving an altered product of nature is
issued, the patent holder is required to deposit a sample of the new invention
into one of the 26 worldwide culture depositories.  Most DNA-related patents are issued by the
USPTO, the European Patent Office, or the Japanese Patent Office.

<P>Currently over three million genome-related patent applications have been filed. 
  U.S. patent applications are confidential until a patent is issued, so determining 
  which sequences are the subject of patent applications is impossible. Those 
  who use sequences from public databases today risk facing a future injunction 
  if those sequences turn out to be patented by a private company on the basis 
  of previously filed patent applications. <BR>
  &nbsp;
<HR>
<P><B><a name="2"></a>Patenting Genes, Gene Fragments, SNPS, Gene Tests, and Proteins</B> 
<P><b>In terms of genetics</b>, inventors must <br>
  (1) identify novel genetic sequences, <br>
  (2) specify the sequence's product, <br>
  (3) specify how the product functions in nature --ie. its use <br>
  (4) enable one skilled in the field to use the sequence for its stated purpose 
<P><B>Genes and Gene Fragments</B> <BR>
  USPTO has issued a few patents for gene fragments. Full sequence and function 
  often are not known for gene fragments. On pending applications, their utility 
  has been identified by such vague definitions as providing scientific probes 
  to help find a gene or another EST or to help map a chromosome. Questions have 
  arisen over the issue of when, from discovery to development into useful products, 
  exclusive right to genes could be claimed. 
<P>
The 300- to 500-base gene fragments, called expressed sequence tags (ESTs), represent only 10
to 30% of the average cDNA, and the genomic genes are often 10 to 20 times larger than the
cDNA.  A cDNA molecule is a laboratory-made version of a gene that contains only its
information-rich (exon) regions; these molecules provide a way for genome researchers to
fast-forward through the genome to biologically important areas. The original chromosomal
locations and biological functions of the full genes identified by ESTs are unknown in most cases.
<P> Patent applications for such gene fragments have sparked controversy among 
  scientists, many of whom have urged the USPTO not to grant broad patents in 
  this early stage of human genome research to applicants who have neither characterized 
  the genes nor determined their functions and uses. 
<P> In December 1999, the USPTO issued stiffer interim guidelines stating that 
  more usefulness must now be shown before gene fragments are considered patentable--specifically 
  how the product functions in nature. The new rules call for "specific and substantial 
  utility that is credible," but some still feel the rules are too lax. 
<P> The patenting of gene fragments is controversial. Some say that patenting 
  such discoveries is inappropriate because the effort to find any given EST is 
  small compared with the work of isolating and characterizing a gene and gene 
  product, finding out what it does, and developing a commercial product. They 
  feel that allowing holders of such "gatekeeper" patents to exercise undue control 
  over the commercial fruits of genome research would be unfair. Similarly, allowing 
  multiple patents on different parts of the same genome sequence --say on a gene 
  fragment, the gene, and the protein-- adds undue costs to the researcher who 
  wants to examine the sequence. Not only does the researcher have to pay each 
  patent holder via licensing for the opportunity to study the sequence, he also 
  has to pay his own staff to research the different patents and determine which 
  are applicable to the area of the genome he wants to study. 
<P><B>SNPs</b><BR>
Single nucleotide polymorphisms (SNPs) are DNA sequence variations that occur when a single
nucleotide (A,T,C,or G) in the genome sequence is altered. For example a SNP might change the
DNA sequence AAGGCTAA to ATGGCTAA. SNPs occur every 100 to 1000 bases along the
3-billion-base human genome. SNPs can occur in both coding (gene) and noncoding regions of
the genome. Many SNPs have no effect on cell function, but scientists believe others could
predispose people to disease or influence their response to a drug. 
<P> Variations in DNA sequence can have a major impact on how humans respond to 
  disease; environmental insults such as bacteria, viruses, toxins, and chemicals; 
  and drugs and other therapies. This makes SNPs of great value for biomedical 
  research and for developing pharmaceutical products or medical diagnostics. 
  Scientists believe SNP maps will help them identify the multiple genes associated 
  with such complex diseases as cancer, diabetes, vascular disease, and some forms 
  of mental illness. These associations are difficult to establish with conventional 
  gene-hunting methods because a single altered gene may make only a small contribution 
  to the disease. 
<P> In April 1999, ten large pharmaceutical companies and the U.K. Wellcome Trust 
  philanthropy announced the establishment of a non-profit foundation to find 
  and map 300,000 common SNPs. Their goal is to generate a widely accepted, high-quality, 
  extensive, publicly available map using SNPs as markers evenly distributed throughout 
  the human genome. The consortium plans to patent all the SNPs found, but they 
  will not enforce the patents. This will be done only as a measure to prevent 
  others from patenting the same information. Information found by the consortium 
  is being made freely available via NIH's NCBI public <a
href="http://www.ncbi.nlm.nih.gov/SNP/">Database of Single Nucleotide Polymorphisms</a>. 
<P><B>Gene Tests</B><BR>
  As disease genes are found, complementary gene tests are developed to screen 
  for the gene in humans who suspect they may be at risk for developing the disease. 
  These tests are usually patented and licensed by the owners of the disease gene 
  patent. Royalties are due the patent holder each time the tests are administered, 
  and only licensed entities can conduct the tests. 
<P><B>Proteins</b>
<P>Proteins do the work of the cell. A complete set of genetic information is 
  contained in each cell. This information provides a specific set of instructions 
  to the body. The body carries out these instructions via proteins. Genes encode 
  for proteins. 
<P> All living organisms are composed largely of proteins. They have three main 
  cellular functions. Enzymes are proteins. Proteins provide cell structure and 
  are involved in cell signaling and cell communication functions.
<P> Proteins are important to researchers because they are the link between genes 
  and pharmaceutical development. They indicate which genes are expressed or are 
  being used. They are important for understanding gene function. They also have 
  unique shapes or structures. Understanding these structures and how potential 
  pharmaceuticals will bind to them is a key element in drug design. 
<P>




<HR>
<P> <B><a name="3"></a>Why patent?</b> 
<P>
Research scientists who work in public institutions often are troubled by the concept of
intellectual property because their norms tell them that science will advance more rapidly if
researchers enjoy free access to knowledge. By contrast, the law of intellectual property rests on
an assumption that, without exclusive rights, no one will be willing to invest in research and
development (R&D).
<P>
Patenting provides a strategy for protecting inventions without secrecy. A patent grants the right
to exclude others from making, using, and selling the invention for a limited term, 20 years from
application filing date in most of the world. To get a patent, an inventor must disclose the
invention fully so as to enable others to make and use it. Within the realm of industrial research,
the patent system promotes more disclosure than would occur if secrecy were the only means of
excluding competitors. This is less clear in the case of public-sector research, which typically is
published with or without patent protection.
<P> The argument for patenting public-sector inventions is a variation on the 
  standard justification for patents in commercial settings. The argument is that 
  postinvention development costs typically far exceed preinvention research outlays, 
  and firms are unwilling to make this substantial investment without protection 
  from competition. Patents thus facilitate transfer of technology to the private 
  sector by providing exclusive rights to preserve the profit incentives of innovating 
  firms. Patents are generally considered to be very positive things. In the case 
  of genetic patenting, it is the scope and number of claims that has generated 
  controversy.
<P><B><a name="4"></a>What are some of the potential arguments for gene patenting?</B> 
<UL>
  <LI>Researchers are rewarded for their discoveries and can use monies gained 
    from patenting to further their research 
    <P> 
  <LI>The investment of resources is encouraged by providing a monopoly to the 
    inventor and prohibiting competitors from making, using, or selling the invention 
    without a license. 
    <P> 
  <LI>Wasteful duplication of effort is prevented. 
    <P> 
  <LI> Research is forced into new, unexplored areas. 
    <P>
  <LI>Secrecy is reduced and all researchers are ensured access to the new invention. 
</ul>

<P><B><a name="5"></a>What are some of the potential arguments against gene patenting?</B> 
<UL>
<li>Patents of partial and uncharacterized cDNA sequences will reward those who 
  make routine discoveries but penalize those who determine biological function 
  or application (inappropriate reward given to easiest step in the process). 
<P><LI>Patents could impede the development of diagnostics and therapeutics by third 
  parties because of the costs associated with using patented research data.
<P><LI>Patent stacking (allowing a single genomic sequence to be patented in several 
  ways such as an EST, a gene, and a SNP) may discourage product development because 
  of high royalty costs owed to all patent owners of that sequence; these are 
  costs that will likely be passed on to the consumer. 
<P><LI>Because patent applications remain secret until granted, companies may work 
  on developing a product only to find that new patents have been granted along 
  the way, with unexpected licensing costs and possible infringement penalties.
<P><LI>Costs increase not only for paying for patent licensing but also for determining 
  what patents apply and who has rights to downstream products. 
<P><LI>Patent holders are being allowed to patent a part of nature --a basic constituent 
  of life; this allows one organism to own all or part of another organism. 
<P><LI>Private biotechs who own certain patents can monopolize certain gene test markets.
<P><LI>Patent filings are replacing journal articles as places for public disclosure 
  --reducing the body of knowledge in the literature. 
</ul>
<HR>
<P><B><a name="6"></a>What does U.S. patent policy say about gene patenting?</B> 
<UL>
  <LI><b>1980 Diamond v. Chakrabarty</b> <br>
    Prior to 1980, life forms were considered a part of nature and were not patentable.&nbsp; 
    Diamond v Chakrabarty changed this with the 5-4 U.S. Supreme Court decision 
    that genetically engineered (modified) bacteria were patentable because they 
    did not occur naturally in nature. In this case, Chakrabarty had modified 
    a bacteria to create an oil-dissolving bioengineered microbe. 
<P> 
 <LI>Since Diamond v. Chakrabarty, patents have been issued on whole genes whose 
    function is known. More recently inventors began to seek patents on sequences 
    of DNA that were less than a whole gene. The Patent Office is currently developing 
    guidelines on how to deal with these fragments since they often do not have 
    a known function.
<P>
  <LI>Some patents have already been granted for fragments of DNA. That presents 
    the problem of someone trying to patent a larger fragment or gene that contains 
    the already patented sequence. Questions have been raised as to whether the 
    second inventor will need to obtain a license from the first or whether he 
    can obtain the patent without the first patent holder's permission. These 
    types of questions are likely to arise in the near future and will most likely 
    be resolved in the courts designated to hear patent actions. 
    <P> 
  <LI>Patents have been prohibited by congress only in a few cases where the issuance 
    of a patent was contrary to the public interest.&nbsp; An example of this 
    was the prohibition of patents on nuclear weapons.&nbsp; The American Medical 
    Association has made a similar request against the patenting of medical and 
    surgical procedures. 
    <P> 
  <LI>U.S. House of Representatives Oversight Hearing on "<a href="http://www.house.gov/judiciary/ct071300.htm">Gene 
    Patents and Other Genomic Inventions</a>" Thursday, July 13, 2000. Related 
    <a href="../publicat/hgn/v11n1-2/09box.html">HGN article</a>.
</ul>
<HR>
<P><B><a name="7"></a>How does genome information placed in the public domain 
  work? Who can use it?</b> 
<P> All of the genome sequence generated by the Human Genome Project has been 
  deposited into GenBank, a public database freely accessible by anyone with a 
  connection to the Internet. 
<P> Disseminating information in the public domain encourages widespread use of 
  information, minimizes transaction costs, and makes R&D cheaper and faster. 
  Of particular relevance to research science, a vigorous public domain can supply 
  a meeting place for people, information, and ideas that might not find each 
  other in the course of more organized, licensed encounters. Information in the 
  public domain is accessible to users who otherwise would be priced out of the 
  market. 
<HR>
<P><b>Related Links</b>
<UL>
        <li><a href="http://www.uspto.gov/patft/">US Patent and Trademark Office</a> 
        <li><a href="http://www.epo.co.at">European Patent Office</a> 
  <li><a href="http://www.gene.ucl.ac.uk/hugo/patent2000.html">HUGO statement 
    on the Patenting of DNA Sequences</a>, April 2000
  <li><a href="http://www.gene.ucl.ac.uk/hugo/patent.htm">HUGO statement on the 
    Patenting of DNA Sequences</a>, January 1995
  <li><a href="http://www.geneletter.com/archives/dna1.html"><i>Gene 
    Letter</i> Patenting Primer</a> 
  <li><a href="http://www.nal.usda.gov/bic/Biblios/patentag.htm">Biotechnology: 
    Patenting Issues</a> 
        <li><a href="http://www.gene-watch.org/">Council for Responsible Genetics</a> 
        <li><a href="http://www.patents.com">Patents.com Intellectual Property Law Web 
    Server</a> 
  <li><a href="http://metalab.unc.edu/patents/intropat.html">Patents: Source Translation 
    &amp; Optimization's Internet Patent Search System</a> 
  <li><a href="http://www.library.ubc.ca/patscan">PATSCAN: Patent and Trademark 
    Searching</a> 
  <li><a href="http://www.nal.usda.gov/bic/Biotech_Patents/">Ag Biotechnology 
    Patents and New Technologies</a> 
  <li><a href="http://www.dnapatent.com/">DNAPatent.com </a> 
</ul>
<P><b>Articles</b> 
<P><a href="http://www.sciencemag.org/cgi/content/full/291/5507/1194">Will a Smaller 
  Genome Complicate the Patent Chase?</a>--<i>Science</i> article, February 2001 
<P><a href="http://www.nature.com/cgi-taf/DynaPage.taf?file=/nature/journal/v409/n6822/full/409763a0_fs.html">Patents 
  in a Genetic Age</a>--<i>Nature</i> article, February 2001
<P><a href="http://www.signalsmag.com/signalsmag.nsf/0/FD168FB6C42ACF6E882568950015E2D0">Homestead 
  2000: The Genome</a> --<i>Signals Magazine</i> article, March 2000 
<P><a href="http://news.bmn.com/hmsbeagle/74/daily/sreport">Patenting Genes: Is 
  it Necessary, and Is it Evil?</a> <i>--HMS Beagle</i> article March 17, 2000 
<P><a href="http://www.sciencemag.org/cgi/content/summary/287/5456/1196">Patent 
  Office May Raise the Bar on Gene Claims</a> --<i>Science</i> 287(5456); 18 Feb 
  2000, pp 1196-1197.
      <P> <a href="http://www.cnn.com/SPECIALS/2000/genome/story/interviews/cook-deegan.html">Interview 
        with Robert Cook-Deegan on Patenting</a> --CNN 1999 
      <P><i>The Scientist</i> articles 
<UL>
  <LI><a href="http://www.the-scientist.com/yr2000/mar/steinberg_p13_000320.html">PTO 
    Explains Proposed Guidelines</a> March 2000
  <LI><a href="http://www.the-scientist.com/yr2000/mar/steinberg_p8_000306.html">Biotech 
    Faces Evolving Patent System</a> March 2000
  <LI><a href="http://www.the-scientist.com/yr1999/oct/bunk_p7_991011.html">Researchers 
    Feel Threatened by Disease Gene Patents</a> October 1999
</ul>
<P><i>Human Genome News</i> Articles 
<UL>
  <LI><a href="../publicat/hgn/v11n1-2/09patent.html">Gene Patenting Update: U.S. 
    PTO Tightens Requirements</a> Nov. 2000
  <LI><a href="../publicat/hgn/v11n1-2/09box.html">Witnesses Testify About Patenting 
    Genes</a> Nov. 2000
  <LI><a href="http://www.ornl.gov/hgmis/publicat/hgn/v8n1/10patent.html">Commercial 
    Strategies Aim to Spin DNA Threads into Gold</a> Sept. 1996 
  <LI><a href="http://www.ornl.gov/hgmis/publicat/hgn/v8n1/11patbox.html">Industry 
    Moves DNA Patenting Forward</a> Sept. 1996 
  <LI> <a href="http://www.ornl.gov/hgmis/publicat/hgn/v8n1/03capebi.html">Genetic 
    Privacy and Property: Perspectives from Capitol Hill </a>Sept. 1996 
</ul>
<P>&nbsp;
<p>&nbsp;
<hr>
<P>Information on this page was compiled from numerous sources including but not 
  limited to HUGO, <i>Science</i>, <i>The Scientist,</i> <i>Gene Letter,</i> <i>HMS 
  Beagle</i>, <i>Signals</i> Magazine, and <i>Human Genome News</i>. 
<P>A special thanks to Chris Dummer at Oak Ridge National Laboratory for her review 
  and comments on this page. 
<P> 
<!-- </td></tr></table> -->
 </td></tr></table> 
<p><font size="-1">To read pdf files, download the free <a href="http://www.adobe.com/products/acrobat/readstep2.html">Acrobat 
  Reader</a> software.</font></p>
<hr>
<small>Last modified:  Wednesday, February 13, 2002</small> 
<p><FONT SIZE=-1><A href="http://www.ornl.gov/hgmis/">Home</A> * <A href="http://www.ornl.gov/hgmis/search.html">Search</A> 
  * <A href="http://www.ornl.gov/hgmis/contact.html">Contacts</A> * <A href="http://www.ornl.gov/hgmis/credits.html">Disclaimer</A></FONT> 
</p>
<p><I>Base URL: www.ornl.gov/hgmis</I></p>
<p>Site sponsored by the <a href="http://www.er.doe.gov/">U.S. Department of Energy 
  Office of Science</a>, <a href="http://www.er.doe.gov/production/ober/ober_top.html">Office 
  of Biological and Environmental Research</a>, <a href="http://www.science.doe.gov/ober/hug_top.html">Human 
  Genome Program</a></p>

</body>
</html> 



